BioArctic said China accepted Eisai’s filing for an at-home Leqembi autoinjector for early Alzheimer’s disease. Swedish biopharma company BioArctic said its partner Eisai has filed a subcutaneous ...
TOKYO and CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB ...
Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback